Oncotarget

Research Papers:

Inhibition of tumor cell growth by adenine is mediated by apoptosis induction and cell cycle S phase arrest

Ming Han, Xin Cheng, Zhiqin Gao, Rongrong Zhao and Shizhuang Zhang _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:94286-94296. https://doi.org/10.18632/oncotarget.21690

Metrics: PDF 1964 views  |   HTML 2005 views  |   ?  


Abstract

Ming Han1, Xin Cheng2, Zhiqin Gao3, Rongrong Zhao4 and Shizhuang Zhang4

1School of Clinical Medicine, Weifang Medical University, Weifang 261053, China

2Department of Medical Imaging, Weifang Medical University, Weifang 261053, China

3School of Bioscience and Technology, Weifang Medical University, Weifang 261053, China

4Medical Imaging Center, Affiliated Hospital of Weifang Medical University, Weifang 261031, China

Correspondence to:

Shizhuang Zhang, email: [email protected]

Keywords: adenine, adenosine, cell cycle, apoptosis

Received: June 22, 2017    Accepted: September 21, 2017    Published: October 09, 2017

ABSTRACT

Gekko swinhonis has a long standing history in Chinese traditional medicine recognized for its application in treating patients with terminal cancer.In order to discover novel anticancer drugs with high anti-tumor efficacy and low toxicity to normal cells, we aim to investigate the anti-tumor components from Gekko swinhonis.Four nucleosides from the extracted samples were enriched, namely adenosine, guanosine, thymidine and inosine. We evaluated the antitumor effect of the four nucleosides and found that adenosine possessed the strongest anti-tumor effect. Besides, adenine could inhibit the growth of Bel-7402 and Hela cells in a dose and time dependent manner, but not normal human cervical keratinocytes. Bel-7402 and Hela cells had undergone apoptosis 48 hours after treatment as evidenced by morphologic changes under TEM, while adenine blocked cell cycle of tumor cells at S phase and subsequently causing cell cycle exit and promoting apoptosis. Moreover, the pharmacokinetics of adenine was stable in cell culture medium for up to 72 hours. Combining its potency with stability, we conclude adenine makes a promising candidate for an anti-tumor drug.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21690